Analysis of two major anti-M2 antibodies (anti-PDC-E2/anti-BCOAD C-E2) in primary biliary cirrhosis: relationship to titers of immunofluorescent anti-mitochondrial antibody
H. Miyakawa et al., Analysis of two major anti-M2 antibodies (anti-PDC-E2/anti-BCOAD C-E2) in primary biliary cirrhosis: relationship to titers of immunofluorescent anti-mitochondrial antibody, HEPATOL RES, 18(1), 2000, pp. 1-9
To analyze anti-M2 components in primary biliary cirrhosis (PBC) we measure
d two major anti-M2 antibodies (anti-PDC-E2 and anti-BCOADC-E2) by immunobl
otting and ELISA, and compared the results between 38 immunofluorescent ant
i-mitochondrial antibody (AMA)-negative PBC patients (group A) and 39 stron
gly AMA-positive PBC patients (group B) with titers of 1:640. Using bovine
heart mitochondrial fraction as antigen, the immunoblot positivity rate of
anti-PDC-E2 in group B was significantly higher than that in group A, where
as the positivity rate of anti-BCOADC-E2 was not significantly different be
tween the two groups. This result was similar to that obtained by ELISA usi
ng recombinant fusion proteins. In group A there was a significant inverse
correlation between ELISA optical density values of anti-PDC-E2 and of anti
-BCOADC-E2, but in group B there was no correlation between the two values.
Only three patients from group A and 21 from group B were positive for bot
h antibodies. Taken together these results appear to indicate that the dete
ction of anti-BCOADC-E2 is critical for the accurate serological diagnosis
of AMA-negative PBC patients. The detection of anti-BCOADC-E2 may also help
to distinguish between AMA-negative PBC and autoimmune cholangitis patient
s. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.